NANOSPHERE INC
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | $21.1M | $3.3M | $2.4M | $5.1M | $2.5M | $2.0M |
| Operating income | −$27.7M | −$9.6M | −$8.5M | −$32.9M | −$35.5M | −$41.4M |
| Net income | −$30.6M | −$10.0M | −$8.5M | −$32.9M | −$35.4M | −$40.6M |
| Total assets | $40.6M | $42.4M | $59.4M | $47.5M | $50.3M | $51.4M |
| Total liabilities | $22.1M | $15.8M | $16.2M | $5.2M | $4.7M | $6.9M |
| Equity | $18.6M | $26.7M | $43.1M | $42.2M | $45.6M | $44.5M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 117.3M | 76.9M | 56.1M | 44.1M | 44.1M | 28.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- −131.4%
- Net margin
- −145.2%
- Return on equity
- −164.6%
- Return on assets
- −75.3%
- Return on capital (ROCE)
- −149.1%
- Liabilities / assets
- 54.3%
- Debt / equity
- 1.19×
- Book value / share
- $0.16
- Revenue growth (YoY)
- 541.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Altman Z″ (distress)
- -38.75distress
- Accruals / assets
- −12.3%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 12, 2015
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Change in control · Amended charter or bylaws · Regulation FD disclosureJun 30, 2016
- Regulation FD disclosureJun 27, 2016
- Regulation FD disclosure · Other material eventJun 2, 2016
- Regulation FD disclosureMay 24, 2016
- Regulation FD disclosureMay 23, 2016
- Entered a material agreementMay 23, 2016
- Regulation FD disclosureMay 20, 2016
- Regulation FD disclosureMay 18, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.